These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9214285)

  • 1. [Oral cephalosporins in the treatment of suppurative-inflammatory diseases].
    Sidorenko SV
    Antibiot Khimioter; 1996; 41(11):33-42. PubMed ID: 9214285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral cephalosporins].
    Kees F
    Med Monatsschr Pharm; 1992 Jan; 15(1):2-10. PubMed ID: 1542277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral cephalosporins of the 3rd generation].
    Kraeft H
    Internist (Berl); 1996 Mar; 37(3):319-23. PubMed ID: 8919952
    [No Abstract]   [Full Text] [Related]  

  • 4. Microbiology of oral cephalosporins.
    Cullmann W
    Antibiot Chemother (1971); 1995; 47():72-109. PubMed ID: 8554308
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cedex (ceftibuten)--a 3rd-generation cephalosporin for internal use].
    Sidorenko SV
    Eksp Klin Farmakol; 1996; 59(3):64-71. PubMed ID: 8974589
    [No Abstract]   [Full Text] [Related]  

  • 6. [The cephalosporins. I].
    Fossati C
    Clin Ter; 1978 Jan; 84(2):167-93. PubMed ID: 348382
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significant role of new oral cephem antibiotics. Focused on cefditoren pivoxil: discussion].
    Shimada K
    Jpn J Antibiot; 1994 Aug; 47(8):951-66. PubMed ID: 7933539
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and efficacy of cefprozil as part of a parenteral-oral antibiotic regimen for the treatment of suppurative skeletal infections in children.
    Trujillo M; Ehrett S; Hoyt-Sehnert MJ; Shelton S; McCracken GH
    Clin Infect Dis; 1996 Oct; 23(4):843. PubMed ID: 8909865
    [No Abstract]   [Full Text] [Related]  

  • 9. The penicillins and cephalosporins. Choosing among the newer agents.
    Wagner KF; Counts GW
    Postgrad Med; 1978 Sep; 64(3):109-16. PubMed ID: 100772
    [No Abstract]   [Full Text] [Related]  

  • 10. [A clinical study on cefdinir 10% granule in pediatrics].
    Satoh Y; Iwata S; Akita H; Sunakawa K
    Jpn J Antibiot; 1991 Oct; 44(10):1076-82. PubMed ID: 1762164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory and clinical studies of cefprozil in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Takagi M
    Jpn J Antibiot; 1992 Nov; 45(11):1582-91. PubMed ID: 1494239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of cefdinir 10% granules in children].
    Meguro H; Mori A; Fujii R; Terashima I
    Jpn J Antibiot; 1991 Oct; 44(10):1061-8. PubMed ID: 1762162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cephalosporins for use in a parenteral-to-oral switch programme.
    Rimmer DM
    Infection; 1995; 23 Suppl 2():S87-90. PubMed ID: 8537139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of new oral antimicrobial agents and the experience with cefprozil--a broad-spectrum oral cephalosporin.
    Klein JO
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S183. PubMed ID: 1617035
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibiotic therapy: cephalosporins].
    Pinto L; Iolascon A; Vitale R; Nobili B
    Pediatria (Napoli); 1979 Sep; 87(3):471-91. PubMed ID: 398976
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetic, bacteriological and clinical studies on cefprozil in pediatric patients].
    Arai S; Sono R; Ito M; Sakurai M; Ihara T; Kamiya H; Shimizu S; Nishi H; Inoue M; Kojima M
    Jpn J Antibiot; 1992 Nov; 45(11):1571-81. PubMed ID: 1494238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.
    Neu HC
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S88-92. PubMed ID: 7567316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory and clinical studies on cefprozil granules in pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1992 Nov; 45(11):1526-36. PubMed ID: 1494235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies on 10% cefdinir granules in pediatric infections].
    Niinou K; Nakazawa S; Sato H
    Jpn J Antibiot; 1991 Oct; 44(10):1069-75. PubMed ID: 1762163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [new antimicrobial agent, cefpirome].
    Kobayashi H
    Jpn J Antibiot; 1994 May; 47(5):441-60. PubMed ID: 8051790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.